Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 4:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1729–1752 of 4,342 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Time Management Clear all

Conditions: Head And Neck Cancer
Interventions: Placebo, Armodafinil, Minocycline, Bupropion; Other · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Gestational Diabetes, Postpartum
Interventions: Dexcom Stelo real-time Continuous Glucose Monitor; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Santa Barbara, California • Portland, Oregon • Philadelphia, Pennsylvania

Conditions: Epidermolysis Bullosa Dystrophica, Recessive
Interventions: FCX-007; Genetic
Lead sponsor: Castle Creek Biosciences, LLC.; Industry
Eligibility: 7 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 2
States / cities: Stanford, California • Aurora, Colorado

Conditions: Acute Musculoskeletal Pain, Chronic Pain
Interventions: Educational Video, Telecare, Correspondence with Primary Care Provider; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Cardiac Rehabilitation, Cardiovascular Diseases
Interventions: Women only Cardiac Rehab program, Standard of Care (mixed-sex) rehab program; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 40 Years to 80 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Burnout, Professional
Interventions: Apollo Wearable; Device
Lead sponsor: Michelle Thompson; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Analgesia
Interventions: HFVI; Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 75 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Surgical Complication, Physical Therapy, Timed Up and Go
Interventions: Functional Assessment, Prehabilitation; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 50 Years to 89 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: Healthy
Interventions: Listerine Cool Mint, Colgate Cavity Protection Toothpaste, Reach Unflavored Waxed Dental Floss, American Dental Association (ADA) Ref Toothbrush; Other
Lead sponsor: Johnson & Johnson Consumer Inc. (J&JCI); Industry
Eligibility: 18 Years to 60 Years
Enrollment: 209 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Fort Wayne, Indiana

Conditions: Bereavement
Interventions: ADAPT; Behavioral
Lead sponsor: East Carolina University; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 2
States / cities: St Louis, Missouri • Akron, Ohio

Conditions: Physical Medicine
Interventions: Ambulation, Standard of Care; Behavioral · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 66 Years to 100 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Amputation, Diabetes Mellitus, Peripheral Artery Disease
Interventions: Walking Biobehavioral Intervention, Attention Control; Behavioral · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 50 Years to 85 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Obesity
Interventions: IncentaHealth; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: David City, Nebraska

Conditions: Diabetic Foot Ulcer
Interventions: Dual-layer perinatal tissue allograft, Three-layer fenestrated perinatal tissue allograft, Standard of care; Other
Lead sponsor: Samaritan Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Monroe, North Carolina

Conditions: Regional Anesthesia Morbidity
Interventions: Ultrasound guidance for caudal block; Diagnostic Test
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Up to 7 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Interventions: MK-1092, 4.0 nmol/kg, MK-1092, 8.0 nmol/kg, MK-1092, 16 nmol/kg, MK-1092, 32 nmol/kg, MK-1092, 64 nmol/kg, Glargine 3.0 nmol/kg, Lispro 1.2 nmol/kg, Placebo to glargine, Placebo to MK-1092, Dextrose, Insulin; Drug · Other · Biological
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Hepatocellular Carcinoma, Squamous Cell Carcinoma of the Lung, Merkel Cell Carcinoma, Myxoid/Round Cell Liposarcoma
Interventions: CAR-GPC3 T Cells; Biological
Lead sponsor: Sotio Biotech Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2042
U.S. locations: 5
States / cities: Newport Beach, California • Dallas, Texas • Houston, Texas + 2 more

Conditions: Neural Tube Defects, Contraception, Oral Contraceptives (OC)
Interventions: Drospirenone/Ethinylestradiol/Methyltetrahydrofolate, Drospirenone/Ethinylestradiol (Yaz); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 385 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 9
States / cities: Anaheim, California • San Diego, California • Baltimore, Maryland + 6 more

Conditions: Rheumatoid Arthritis -Exposure During Pregnancy
Interventions: Sarilumab SAR153191 (REGN88); Drug
Lead sponsor: Sanofi; Industry
Eligibility: Female only
Enrollment: 113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Relapsed Refractory Multiple Myeloma (RRMM), Relapsed Refractory Multiple Myeloma
Interventions: elranatamab, Isatuximab SC, Isatuximab SC-OBDS; Drug · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Diabetes Mellitus, Type 1, Diabetes Complications
Interventions: Device specific training, Study clinician/educator visit; Device · Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Boston, Massachusetts • The Bronx, New York

Conditions: Tinnitus
Interventions: Progressive Tinnitus Management, Wait List Control; Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 3
States / cities: West Haven, Connecticut • Portland, Oregon • Memphis, Tennessee

Conditions: Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neuroblastoma
Interventions: Biopsy Procedure, Bone Marrow Aspiration, Bone Marrow Biopsy, Carboplatin, Clinical Observation, Computed Tomography, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Magnetic Resonance Imaging, Ultrasound; Procedure · Drug · Other
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 18 Months
Enrollment: 391 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2027
U.S. locations: 193
States / cities: Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 147 more

Conditions: Asthma
Interventions: Asthma Supervision, Mobile Phone, Inhaled Corticosteroid Mobile Phone Application, Beta2-adrenergic agonist Mobile Phone Application; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 11 Years to 16 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Symptom Burden in Head and Neck Cancer

Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness

A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Reducing the Transition From Acute to Chronic Musculoskeletal Pain Among Older Adults

Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program

Impact of Heart Rate Variability Modulation on Stress Management Among Physicians

Confirmatory Study of HFVI Guided Analgesic Administration in Surgical Subjects

Functional Prehabilitation and Major Elective Surgery

A Twelve Week Study of Virtually Supervised Mouth Rinse and Flossing

Pilot Testing ADAPT a Bereavement Care Intervention

Association Between Inpatient Steps Per Day and Patient Functional Status/Disposition

Dysvascular Amputation Self-Management of Health

Examining Reach and Implementation of an Evidence-based Weight Loss Program in Rural Primary Care

Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

Does Use of Ultrasound Reduce the Rate of Sham Caudal Block in Children

Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

Efficacy and Safety Study for an Oral Contraceptive Containing Folate

An Observational Study on Sarilumab-exposed Pregnancies

ELISA in Relapsed/Refractory MM

Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

Multi-Site Evaluation of Progressive Tinnitus Management

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Using Mobile Phones to Improve Adherence to Inhaled Steroids